TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 132 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $541,000 | +33.3% | 7,459 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $406,000 | -20.5% | 7,459 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $511,000 | +10.6% | 7,459 | 0.0% | 0.00% | -25.0% |
| Q1 2020 | $462,000 | -30.4% | 7,459 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $664,000 | +17.1% | 7,459 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $567,000 | -47.6% | 7,459 | -40.2% | 0.00% | -20.0% |
| Q2 2019 | $1,083,000 | +49.4% | 12,465 | +49.3% | 0.01% | 0.0% |
| Q4 2018 | $725,000 | +2238.7% | 8,347 | +2682.3% | 0.01% | – |
| Q4 2017 | $31,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q3 2017 | $31,000 | -8.8% | 300 | 0.0% | 0.00% | – |
| Q2 2017 | $34,000 | -66.7% | 300 | -54.5% | 0.00% | -100.0% |
| Q4 2015 | $102,000 | – | 660 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL LP | 1,104,068 | $104,886,000 | 77.66% |
| Greywolf Capital Management LP | 472,135 | $46,694,000 | 10.17% |
| Consonance Capital Management LP | 263,732 | $26,083,000 | 4.28% |
| Moab Capital Partners | 83,132 | $8,222,000 | 3.77% |
| Raging Capital Management, LLC | 190,151 | $18,806,000 | 3.45% |
| Valentine Capital Asset Management, Inc. | 145,053 | $14,346,000 | 3.07% |
| Assured Investment Management LLC | 1,353,342 | $133,846,000 | 1.21% |
| Ativo Capital Management LLC | 22,828 | $2,258,000 | 0.99% |
| Perceptive Advisors | 56,602 | $5,598,000 | 0.67% |
| Jaffetilchin Investment Partners, LLC | 7,721 | $764,000 | 0.38% |